The study of ocular infections and immune responses is critical in managing vision-threatening conditions. Ocular microbiology and immunology focus on pathogens like bacteria, viruses, and fungi that cause conjunctivitis, keratitis, and endophthalmitis. Understanding the eye’s immune privilege is vital for developing targeted therapies that minimize inflammation while combating infection. Recent research highlights the role of the ocular microbiome in maintaining homeostasis and its disruption in disease states. Advances in molecular diagnostics, such as PCR-based assays, enable rapid identification of pathogens, improving treatment precision. Immunomodulatory therapies, including biologics, are emerging as effective options for uveitis and other inflammatory disorders. These insights guide clinicians in optimizing antimicrobial and immunosuppressive strategies, ensuring better prognosis for patients with complex ocular conditions.







Title : Lenadogene nolparvovec gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom